COM:CORBUSPHARMA
Corbus Pharmaceuticals Holdings, Inc.
- Stock
Last Close
16.08
21/11 21:00
Market Cap
550.26M
Beta: -
Volume Today
245.36K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -1.34M - | -1.17M 13.05% | 175K 115.01% | |||||||||
average payables | 262.82K - | 829.27K 215.53% | 2.37M 185.45% | 3.28M 38.36% | 4.74M 44.66% | 8.72M 84.02% | 9.24M 5.94% | 4.58M 50.39% | 1.98M 56.83% | 1.59B 80,296.79% | ||
average receivables | 665.21K - | 665.21K 0% | 1.34M - | 2.63M 96.17% | 1.29M 50.98% | |||||||
book value per share | -2.07 - | 8.72 520.79% | 8.60 1.45% | 6.50 24.35% | 34.55 431.14% | 14.49 58.07% | 2.89 80.04% | 17.38 501.32% | 16.86 3.03% | 7.91 53.08% | -1.60 120.17% | |
capex per share | -0.10 - | -0.11 13.78% | -0.26 135.92% | -0.42 64.29% | -1.21 186.26% | -1.29 6.35% | -0.19 85.55% | -0.01 92.90% | -0.00 75.60% | |||
capex to depreciation | -6.19 - | -2.60 58.10% | -4.03 55.18% | -2.77 31.29% | -4.66 68.31% | -2.23 52.12% | -0.29 87.18% | -0.03 88.44% | -0.01 72.65% | |||
capex to operating cash flow | 0.03 - | 0.02 10.10% | 0.03 6.01% | 0.03 2.16% | 0.08 200.62% | 0.06 21.60% | 0.00 91.90% | 0.00 76.87% | 0.00 68.14% | |||
capex to revenue | -0.18 - | -0.18 5.01% | -0.29 56.96% | -0.48 64.55% | -0.08 84.09% | -0.12 62.17% | -0.06 50.07% | |||||
cash per share | 0.35 - | 9.32 2,545.07% | 11.81 26.69% | 10.93 7.40% | 37.39 241.99% | 21.97 41.23% | 14.91 32.16% | 32.80 120.07% | 23.82 27.39% | 14.19 40.41% | 3.17 77.66% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 254.05 - | 27.08 - | 239.02 782.82% | |||||||||
debt to assets | 2.09 - | 0.02 98.95% | 0.01 42.47% | 0.02 22.79% | 0.00 67.80% | 0.01 68.66% | 0.19 2,190.56% | 0.26 36.49% | 0.25 5.91% | 0.38 53.29% | 0.74 95.23% | |
debt to equity | -0.36 - | 0.02 106.88% | 0.02 26.78% | 0.03 71.85% | 0.01 81.39% | 0.01 148.41% | 1.53 10,607.87% | 0.59 61.36% | 0.38 35.09% | 0.76 97.66% | -3.02 497.70% | |
dividend yield | ||||||||||||
earnings yield | -0.01 - | -0.04 441.60% | -0.17 305.97% | -0.06 66.38% | -0.09 58.19% | -0.17 83.77% | -0.20 18.52% | -1.14 474.95% | -0.60 47.24% | -4.02 568.62% | -1.71 57.55% | |
enterprise value | 77.74M - | 54.16M 30.33% | 39.55M 26.97% | 332.90M 741.68% | 294.05M 11.67% | 291.52M 0.86% | 326.59M 12.03% | 39.07M 88.04% | 77.35M 97.97% | 21.98M 71.59% | 33.30B 151,429.74% | |
enterprise value over ebitda | -139.69 - | -20.56 85.28% | -4.49 78.15% | -16.74 272.78% | -9.04 45.99% | -5.13 43.28% | -4.24 17.24% | -0.32 92.46% | -1.37 329.62% | -0.74 45.82% | -0.75 0.24% | |
ev to operating cash flow | -211.99 - | -22.94 89.18% | -8.51 62.90% | -24.53 188.23% | -10.58 56.87% | -9.70 8.35% | -7.14 26.33% | -0.39 94.51% | -1.61 309.57% | -0.59 63.54% | -0.92 57.59% | |
ev to sales | 61.00 - | 174.16 185.51% | 120.50 30.81% | 60.45 49.83% | 9.04 85.05% | 9.92 9.82% | 87.72 784.03% | |||||
free cash flow per share | -0.43 - | -3.61 746.58% | -4.56 26.23% | -10.15 122.86% | -17.04 67.83% | -17.04 0.04% | -22.75 33.56% | -38.46 69.04% | -11.77 69.41% | -9.01 23.47% | -8.34 7.37% | |
free cash flow yield | -0.00 - | -0.04 749.42% | -0.09 128.74% | -0.04 56.48% | -0.08 99.74% | -0.10 21.53% | -0.14 42.86% | -1.03 638.36% | -0.64 37.92% | -2.70 324.73% | -1.38 48.93% | |
graham net net | -2.08 - | 8.22 495.95% | 8.08 1.66% | 5.12 36.66% | 31.89 522.88% | 11.73 63.23% | -4.96 142.30% | 11.72 336.25% | 14.40 22.85% | 6.20 56.91% | -4.96 179.91% | |
graham number | 5.72 - | 27.24 376.59% | 40.48 48.59% | 46.20 14.13% | 122.75 165.70% | 97.73 20.39% | 45.96 52.98% | 129.29 181.34% | 64.92 49.79% | 48.81 24.81% | 19.24 60.59% | |
income quality | 0.61 - | 0.93 52.67% | 0.53 43.50% | 0.68 29.24% | 0.86 26.34% | 0.54 37.01% | 0.64 18.48% | 0.90 40.01% | 1.06 17.84% | 0.89 16.02% | 0.81 8.71% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -12.35 - | -110.20 792.14% | -3.63K 3,192.63% | -177.83 - | 119.42 - | 0.03 99.97% | 18.68 60,984.00% | 15.25 18.35% | ||||
interest debt per share | 0.79 - | 0.25 68.45% | 0.16 37.20% | 0.20 28.08% | 0.31 53.16% | 0.21 32.78% | 4.43 2,036.86% | 9.91 123.45% | -440.01 4,540.40% | 5.50 101.25% | 4.15 24.60% | |
inventory turnover | ||||||||||||
invested capital | -0.36 - | 0.02 106.88% | 0.02 26.78% | 0.03 71.85% | 0.01 81.39% | 0.01 148.41% | 1.53 10,607.87% | 0.59 61.36% | 0.38 35.09% | 0.76 97.66% | -3.02 497.70% | |
market cap | 77.41M - | 60.28M 22.13% | 51.73M 14.18% | 347.61M 572.00% | 356.26M 2.49% | 332.88M 6.56% | 348.89M 4.81% | 97.67M 72.01% | 75.76M 22.43% | 13.89M 81.67% | 26.14B 188,104.66% | |
net current asset value | -1.78M - | 5.79M 424.98% | 8.82M 52.28% | 8.43M 4.43% | 56.31M 567.66% | 24.78M 56.00% | -4.83M 119.50% | 35.05M 825.73% | 61.58M 75.68% | 26.86M 56.38% | -11.63B 43,403.95% | |
net debt to ebitda | -0.60 - | 2.32 485.70% | 1.38 40.46% | 0.74 46.47% | 1.91 158.44% | 0.73 61.96% | 0.29 60.16% | 0.48 65.56% | -0.03 105.87% | -0.27 873.58% | -0.16 41.43% | |
net income per share | -0.70 - | -3.78 439.80% | -8.47 124.03% | -14.58 72.20% | -19.38 32.91% | -29.30 51.16% | -32.47 10.81% | -42.74 31.63% | -11.11 74.00% | -13.39 20.48% | -10.31 23.01% | |
operating cash flow per share | -0.43 - | -3.51 724.09% | -4.45 26.57% | -9.90 122.54% | -16.62 67.92% | -15.82 4.78% | -21.47 35.64% | -38.28 78.31% | -11.75 69.29% | -9.00 23.41% | -8.34 7.33% | |
payables turnover | ||||||||||||
receivables turnover | 1.44 - | 13.48 - | 1.53 88.67% | |||||||||
research and ddevelopement to revenue | 9.08 - | 8.08 11.08% | 10.67 32.13% | 10.08 5.53% | 2.48 75.41% | 24.96 906.74% | 41.34 65.62% | |||||
return on tangible assets | -1.97 - | -0.38 80.48% | -0.69 78.61% | -1.12 62.63% | -0.48 56.70% | -1.18 144.76% | -1.41 18.78% | -1.09 22.68% | -0.42 61.14% | -0.84 99.12% | -1.58 87.37% | |
revenue per share | 0.62 - | 1.39 124.66% | 1.46 4.66% | 2.54 73.96% | 16.97 568.59% | 1.51 91.09% | 0.22 85.77% | |||||
roe | 0.34 - | -0.43 228.28% | -0.99 127.32% | -2.24 127.62% | -0.56 74.98% | -2.02 260.49% | -11.23 455.25% | -2.46 78.11% | -0.66 73.19% | -1.69 156.76% | 6.46 481.69% | |
roic | 0.52 - | -0.44 185.14% | -0.97 117.65% | -2.17 124.51% | -0.55 74.54% | -2.07 274.37% | -3.07 48.24% | -1.53 50.13% | -0.54 64.51% | -0.82 50.87% | -2.39 191.51% | |
sales general and administrative to revenue | 5.57 - | 3.38 39.36% | 3.67 8.70% | 2.69 26.86% | 0.65 75.65% | 7.23 1,005.80% | 23.17 220.25% | |||||
shareholders equity per share | -2.07 - | 8.72 520.79% | 8.60 1.45% | 6.50 24.35% | 34.55 431.14% | 14.49 58.07% | 2.89 80.04% | 17.38 501.32% | 16.86 3.03% | 7.91 53.08% | -1.60 120.17% | |
stock based compensation to revenue | 1.78 - | 1.66 6.95% | 2.33 41.00% | 1.58 32.38% | 0.33 78.99% | 3.16 854.51% | 10.75 239.81% | |||||
tangible asset value | -1.78M - | 5.86M 428.78% | 8.99M 53.26% | 8.92M 0.73% | 57.78M 547.85% | 27.52M 52.37% | 6.16M 77.63% | 45.27M 635.27% | 69.11M 52.64% | 32.99M 52.26% | -6.90B 21,029.73% | |
tangible book value per share | -2.07 - | 8.72 520.79% | 8.60 1.45% | 6.50 24.35% | 34.55 431.14% | 14.49 58.07% | 2.89 80.04% | 17.38 501.32% | 16.86 3.03% | 7.91 53.08% | -1.60 120.17% | |
working capital | -343.35K - | 5.79M 1,787.79% | 9.08M 56.77% | 8.50M 6.39% | 57.30M 573.77% | 26.15M 54.36% | 3.27M 87.51% | 60.18M 1,741.97% | 83.20M 38.25% | 47.54M 42.86% | -8.35B 17,659.61% |
All numbers in (except ratios and percentages)